Sanna Rejnlander, member of the Board in FarmPharma since March 2020. Sanna’s expertise in the Pharmaceutical Industry lies in drug development and chemical industrial processes and also regulatory requirements and quality insurance in the field. Sanna is currently employed as an analyst within nuclear reactor technology and analysis at the Swedish Radiation Safety Authority.

Irina Zaitseva has completed her PhD in Medical Cell Biology from Karolinska Institutet. She is a life science professional with more than 20 years of experience in research. Irina has worked as a Project Coordinator at the innovative pharmaceutical company Double Bond Pharmaceutical AB since September 2019. She has extensive experience in preclinical studies and a profound knowledge of interferon signal transduction. Irina is Board member and CEO of FarmPharma since April 2020.

Sergey Yanitsky, member of the Board in Double Bond Pharmaceutical International AB since April 2015. Sergey´s expertise in the Pharmaceutical Industry lies in manufacturing, marketing and international distribution of pharmaceuticals. He is the founder and CEO of MedInter, which is a vertically integrated pharmaceutical company started in 2001.

Igor Lokot, member of the Board in Double Bond Pharmaceutical International AB since April 2015. Igor is President and Founder of Double Bond Pharmaceutical AB. Igor has a PhD in Bio-organic Chemistry and a wide experience in drug development. Igor is one of the founders of the pharmaceutical company Oasmia Pharmaceutical AB which is listed on NASDAQ Stockholm.